Exploring Painless Strategies For Career For Orthopaedics

career

You’re.bout to open a new window to search for a new career at G. Meet Abelson Santos, a  Lead Services  PROJECT MANAGR at GE Oil & Petrol “The constant push for self-improvement is rewarding.” Learn more Senior Scientist, User Experience Lab, GSA I was fascinated by the vision of ‘Industrial Internet’ and the opportunities of innovations that we can generate here to make the world a better place.” try this web-sitePropose an experiment for a chance to win an intern ship by June 14th. Click here to learn more or request an application acDommodation here . Want to learn more? You’ve made … Sponsored by the U.S. If your resume is not ready to be posted, you may still register with Job.com However, only members that post their resume can be found by those recruiters and employers who are hiring. reflections on wise medical interviews systemsWhat stops you from getting your dream job?

orthopaedics

The calendar is also available on the Bone Therapeutics website under the heading Investors . In addition, Bone Therapeutics announces that it will participate in the following investor conferences in January 2017: 6 January 2017 Oddo Midcap Forum, Lyon (France) 26 January 2017 Invest Securities BioMed Event, Paris (France) -Ends- About Bone Therapeutics Bone Therapeutics is a leading biotechnology company specializing in the development of cell therapy products intended for orthopaedics and bone diseases. The current standard-of-care in this field involves major surgeries and long recovery periods. To overcome these problems, Bone Therapeutics is developing a range of innovative regenerative products containing osteoblastic/bone-forming cells, administrable via a minimally invasive percutaneous technique; a unique proposition in the market. PREOB, Bone Therapeutics autologous bone cell product, is currently in pivotal Phase IIB/III clinical studies for two indications: osteonecrosis and non-union fractures, and in Phase IIA for severe osteoporosis. ALLOB, its allogeneic off-the-shelf bone cell product, is in Phase I/IIA for the treatment of delayed-union fractures, lumbar fusion for degenerative disease of the spine and revision spinal fusion. The Company also runs preclinical research programs and develops novel product candidates. Founded in 2006, Bone Therapeutics is headquartered in Gosselies (South of Brussels, Belgium). Bone Therapeutics regenerative products are manufactured to the highest GMP standards and are protected by a rich IP estate covering 10 patent families.

For the original version including any supplementary images or video, visit http://www.businesswire.com/news/home/20161220006143/en/Bone-Therapeutics-Announces-Financial-Calendar-2017/?feedref=JjAwJuNHiystnCoBq_hl-bNgknBQakQ2FGsSkk8fjL9tm8lMXuEWKyDt85bCjPoCrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3mTATIyvdIvvG64feVLqxGhRzAC4_rGwOLNoA4bcgbFNw==

You may also be interested to read

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>